Skip to main content
. 2023 Apr 28;24(3):416–423. doi: 10.5811/westjem.58959

Table 1.

Categorical variables by phosphate quartile group (unique patients).

Variable Overall Highest quartile Third quartile Second quartile Lowest quartile P-value
Age, years* 60 (50, 71) 64 (53, 74) 60 (49, 73) 59 (49, 70.5) 58 (48, 68) <0.001
Gender, female 950 (51) 219 (54) 233 (52) 238 (52) 260 (48) 0.39
Race, Black 889 (48) 190 (46) 226 (50) 211 (46) 262 (49) 0.34
 Other 92 (5) 14 (4) 18 (4) 25 (5) 34 (6)
 White 874 (47) 204 (50) 207 (46) 220 (48) 243 (45)
AIDS 61 (3) 11 (3) 18 (4) 14 (3) 18 (3) 0.75
Malignancy 210 (11) 47 (11) 56 (12) 50 (11) 57 (11) 0.83
CHF 388 (21) 127 (31) 85 (19) 92 (20) 84 (16) <.001
COPD 629 (34) 149 (36) 145 (32) 184 (40) 151 (28) <.001
CVD 180 (10) 53 (13) 37 (8) 44 (10) 46 (9) 0.08
Diabetes 637 (34) 144 (35) 165 (37) 158 (35) 170 (32) 0.40
Dementia 104 (6) 31 (8) 35 (8) 17 (4) 21 (4) 0.01
Liver disease 207 (11) 47 (11) 45 (10) 53 (12) 62 (12) 0.84
Myocardial infarct 152 (8) 54 (13) 33 (7) 28 (6) 37 (7) <.001
Mechanical vent 116 (6) 50 (12) 28 (6) 21 (5) 17 (3) <.001
Metastatic cancer 78 (4) 16 (4) 22 (5) 19 (4) 21 (4) 0.87
Vasopressors 532 (29) 204 (50) 105 (23) 111 (24) 112 (21) <.001
Calcium, mg/dL*^ 9.1 (8.6, 9.5) 9 (8.4, 9.5) 9.1 (8.6, 9.6) 9 (8.6, 9.5) 9.1 (8.6, 9.5) 0.07
Creatinine, mg/dL *^ 1.09 (0.78, 1.65) 1.73 (1.12, 2.73) 1.11 (0.77, 1.76) 0.94 (8.6, 9.5) 0.99 (0.74, 1.33) <.001
Lactate, mmol/L*^ 2.0 (1.4, 3.1) 2.3 (1.5, 3.9) 1.7 (1.2, 2.8) 1.9 (1.2, 3.0) 2.0 (1.5, 3.0) <.001
SOFA Total*^ 2 (0, 5) 5 (3, 8) 5 (3, 8) 2 (0, 4) 1 (0, 3) <.001

Any malignancy except malignancy skin neoplasm;

metastatic solid tumor; data is reported as count (percentage) and analyzed using chi-square test, unless specified by

*

median (1st quartile, 3rd quartile) and Wilcoxon rank-sum test;

^

first available measure at first encounter.

AIDS, acquired immunodeficiency syndrome; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; CVD, cerebrovascular disease; mg/dL, milligram per deciliter; SOFA, Sequential Organ Failure Assessment,